Sleep spindles may predict response to cognitive behavioral therapy for chronic insomnia by Dang-Vu, Thien Thanh et al.
Accepted Manuscript
Sleep spindles may predict response to cognitive behavioral therapy for chronic
insomnia
Thien Thanh Dang-Vu, MD, PhD, Benjamin Hatch, MA, Ali Salimi, BS, Melodee
Mograss, PhD, Soufiane Boucetta, PhD, Jordan O’byrne, MSc, Marie Brandewinder,




To appear in: Sleep Medicine
Received Date: 2 June 2017
Revised Date: 26 July 2017
Accepted Date: 9 August 2017
Please cite this article as: Dang-Vu TT, Hatch B, Salimi A, Mograss M, Boucetta S, O’byrne J,
Brandewinder M, Berthomier C, Gouin J-P, Sleep spindles may predict response to cognitive behavioral
therapy for chronic insomnia, Sleep Medicine (2017), doi: 10.1016/j.sleep.2017.08.012.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all














Sleep spindles may predict response to cognitive behavioral therapy 
for chronic insomnia 
 
Running head: Spindles and CBT-I response 
 
Thien Thanh DANG-VU1,2,3,4,5,6,7*, MD, PhD, Benjamin HATCH2,3,4, MA, Ali SALIMI1,3,4,6, BS, 
Melodee MOGRASS1,2,4,6, PhD, Soufiane BOUCETTA1,3,4,6, PhD, Jordan O’BYRNE1,3,4,6, MSc, 




1Department of Exercise Science, Concordia University, Montréal, QC, Canada 
2Department of Psychology, Concordia University, Montréal, QC, Canada 
3Center for Studies in Behavioral Neurobiology, Concordia University, Montréal, QC, Canada  
4PERFORM Center, Concordia University, Montréal, QC, Canada 
5Center for Clinical Research in Health, Concordia University, Montréal, QC, Canada 
6Centre de Recherches de l’Institut Universitaire de Gériatrie de Montréal, Montréal, QC, 
Canada 
7Department of Neurosciences, Université de Montréal, Montréal, QC, Canada 
8Physip SA, Paris, France 
 
*Corresponding author: 
T. T. Dang-Vu, MD PhD 
Center for Studies in Behavioral Neurobiology (CSBN), PERFORM Center 
Dpt of Exercise Science, Concordia University 
7141 Sherbrooke St. West, SP 165.27 
Montréal H4B 1R6 
Tel: (514) 848-2424, Ext 3364 
Centre de Recherche de l’Institut Universitaire de Gériatrie de Montréal (CRIUGM) 
Dpt of Neurosciences, Université de Montréal 
4545 chemin Queen-Mary, M6822 
Montréal H3W 1W4 






Author contributions: TTDV and JPG designed the study. BH, AS, SB and JO performed data 
collection. TTDV, BH, AS, MM, MB, CB and JPG performed the analyses. TTDV, BH and JPG 
interpreted the results. TTDV, BH and JPG prepared and wrote the manuscript. All authors 
















Background: While cognitive-behavioral therapy for insomnia constitutes the first-line treatment 
for chronic insomnia, only few reports have investigated how sleep architecture relates to 
response to this treatment. In this pilot study, we aimed at determining whether sleep spindle 
density at pre-treatment predicts treatment response to cognitive behavioral therapy for insomnia.  
Methods: Twenty-four participants with chronic primary insomnia took part in a 6-week 
cognitive behavioral therapy for insomnia performed in groups of 4 to 6 participants. Treatment 
response was assessed using the Pittsburgh Sleep Quality Index and the Insomnia Severity Index 
measured at pre- and post-treatment and at 3- and 12-months follow-up assessments. Secondary 
outcome measures were extracted from sleep diaries over seven days and one overnight 
polysomnography, obtained at pre- and post-treatment. Spindle density during stages N2-N3 
sleep was extracted from polysomnography at pre-treatment. Hierarchical linear modeling 
analysis assessed whether sleep spindle density predicted response to cognitive behavioral 
therapy.  
Results: After adjusting for age, sex and education level, lower spindle density at pre-treatment 
predicted poorer response over the 12-months follow-up, as reflected by smaller reduction in 
Pittsburgh Sleep Quality Index over time. Reduced spindle density also predicted lower 
improvements in sleep diary sleep efficiency and wake after sleep onset immediately after 
treatment. There were no significant associations between spindle density and changes in the 
Insomnia Severity Index or polysomnography variables over time. 
Conclusion: These preliminary results suggest that inter-individual differences in sleep spindle 
density in insomnia may represent an endogenous biomarker predicting responsiveness to 














subtype characterized by a neurophysiological vulnerability to sleep disruption associated with 
impaired responsiveness to cognitive behavioral therapy.  
 

















 Insomnia is one of the most commonly reported sleep complaints with an estimated 6-
10% of adults meeting clinical criteria for chronic insomnia disorder, leading to detrimental 
health consequences and impairment in quality of life [1]. The first-line treatment for chronic 
insomnia is cognitive behavioral therapy for insomnia (CBT-I), a multimodal approach including 
elements such as stimulus control, sleep restriction, sleep hygiene, cognitive restructuring and 
relaxation techniques [2]. CBT-I has well documented efficacy with treatment response rates 
around 60-70% and remission rates around 40% [3, 4]. However, approximately half of those 
treated will maintain persistent insomnia symptoms after CBT-I. In this context the search for 
predictors of CBT-I treatment response is of prime importance to identify individuals who 
should be prioritized for CBT-I.  
 Previous research on predicting treatment outcomes for CBT-I has produced mixed 
results. While demographic variables (e.g., age, sex, education level) were not found to be 
associated with treatment outcome [5-7], some studies reported that greater severity of insomnia 
at baseline predicted better treatment outcomes, but these results were inconsistent across studies 
[5, 7, 8]. Results were also inconsistent for psychological factors: elevated anxiety and 
depression were associated with better CBT-I outcomes in some studies [5] but not others [9]; 
greater dysfunctional beliefs about sleep predicted better CBT-I treatment outcomes [10], but not 
in all studies [7]. Objective sleep duration was also investigated, some studies reporting that 
insomniacs with short sleep showed poorer CBT-I response [11], while others found no 
difference in CBT-I treatment outcome between insomniacs with short sleep and those with 
normal sleep duration [12].  One area that has not received much attention is sleep micro-














electroencephalography (EEG) delta power in the first non-rapid-eye-movement (NREM) sleep 
cycle at pre-treatment predicted better response to CBT-I [13]. To our knowledge, no study has 
specifically assessed sleep spindle activity in relation to CBT-I outcomes.  
 Sleep spindles are transient oscillations of around 11-15 Hz (sigma band) seen in EEG 
recordings that occur predominantly in stage N2, but also persist in stage N3 of NREM sleep. 
They are produced by the interplay of specific thalamic nuclei (reticular thalamic and thalamo-
cortical neurons) and cortical neurons [14]. Spindle activity – as measured by averaged spindle 
density – is considered as an individual trait; while spindle density shows variability between 
individuals, it remains stable across multiple nights within individuals [15, 16]. Interindividual 
differences in spindle activity have been proposed to reflect a genetically determined trait [17]. 
Spindles have been shown to display functional properties that can be grouped in two major 
domains. First, they correlate with overnight improvements of procedural and declarative 
memories as well as with general intellectual abilities, which suggests that spindle density is a 
biomarker of neural development and offline memory consolidation [18, 19]. Second, spindles 
have also been related to the gating of external stimuli, particularly acoustic stimuli, during 
sleep. Neuroimaging studies have shown that sounds played during NREM sleep consistently 
activated the auditory cortex except when the sound occurred during spindles [20]. Furthermore, 
individuals with lower spindle density were shown to be more vulnerable to sleep disruption 
from external sounds than those with higher spindle activity [21]. This suggests that spindles 
serve as a sleep protective mechanism that may help maintain sleep when exposed to noise.  
Lower spindle density might thus affect sleep quality and represent a predisposing factor 
to the development of insomnia. This was demonstrated in a longitudinal study that assessed 














examinations among university students. Individuals with lower spindle density at the start of the 
semester prospectively reported a greater increase in insomnia symptoms towards the end of the 
semester, a period of higher academic stress [22]. However, this finding contrasts with the 
absence of group differences between chronic insomniacs and good sleepers in the number and 
density of sleep spindles [23]. One explanation for these seemingly discrepant findings is that 
chronic insomnia is a broad phenotype that likely encompasses different subtypes with distinct 
aetiologies [24]. Given its relationships with sleep stability and with the development of 
insomnia, spindle activity might constitute a factor distinguishing specific subtypes of 
insomniacs, i.e. a low-spindle insomnia subtype characterized by a neurophysiological trait 
vulnerability to sleep disruption, and a subtype with preserved spindle activity in which other 
factors (e.g. psychological) would play a more predominant role in the persistence of insomnia. 
Such spindle-based phenotyping of chronic insomnia would be likely to impact responsiveness to 
CBT-I, and therefore have clinical relevance. Indeed, CBT-I has been developed to target the 
psychological factors contributing to the perpetuation of insomnia rather than the physiological 
processes associated with insomnia [25], and might thus be less effective for individuals in 
which a neurophysiological vulnerability to insomnia is elicited by a reduced spindle density .  
 The purpose of this pilot study was to assess whether inter-individual differences in 
spindle density prospectively predict response to CBT-I among chronic primary insomniacs. 
Primary outcomes of interest were changes in sleep quality and insomnia severity questionnaires 
(Pittsburgh Sleep Quality Index, PSQI; Insomnia Severity Index, ISI) from pre-treatment to 12 
months post-treatment. Secondary outcomes were pre- to immediate post-treatment changes in 
PSQI, ISI, as well as sleep variables derived from sleep diaries and polysomnography (PSG). 














hypothesized that insomniacs with lower spindle density would show poorer improvement in 
CBT-I outcomes, compared to those with higher spindle density. 
 
MATERIALS AND METHODS 
 
Participants 
 Participants with chronic primary insomnia were recruited via online and print 
advertisements posted in the community as well as from physician referral. Prospective 
participants were initially screened over the phone for inclusion and exclusion criteria, followed 
by a semi-structured in-person medical interview. During that interview, eligibility was reviewed 
and confirmed by a licensed neurologist with expertise in sleep medicine (TD). Participants had 
to meet the ICSD-3 diagnostic criteria for chronic insomnia disorder, which were operationalized 
as difficulties initiating sleep (defined as a sleep onset latency greater than 30 min.) and/or 
difficulties maintaining sleep (defined as wake after sleep onset greater than 30 min.) and/or 
early morning awakenings (defined as final awakening time earlier than desired by at least 30 
min.), combined with significant impairment of daytime functioning, for a duration of three 
months or more with sleep disturbances three times a week or more [26]. Exclusion criteria were 
being less than 18 years of age, having major psychiatric or medical conditions including sleep 
disorders other than insomnia (e.g., sleep apnea, restless legs syndrome and periodic limb 
movement disorder), recent shift work or changes in time zones over the past 2 months, and 
using recreational drugs or prescription drugs that might affect sleep. If currently taking sleep 
medication, participants were asked to stop that medication at least 1 week before the first PSG 














underwent a screening PSG to rule out the presence of other sleep disorders contributing to 
insomnia symptoms, particularly sleep apnea and periodic limb movement disorder (an apnea-
hypopnea index > 5/h and an index of periodic limb movements during sleep > 15/h were 
exclusion criteria). Out of 86 potential participants screened over the phone, a total of 49 
completed the in-person semi-structured interview; 38 were deemed eligible and 29 agreed to 
enter the study protocol. Of those, 2 dropped out midway through the CBT-I sessions for 
personal reasons, 2 completed the CBT-I sessions but dropped out before the post-treatment 
assessments, and 1 was excluded due to presenting persistent flu-like symptoms during the 
course of the CBT-I sessions. In total, 24 (19 females, 5 males; Mage = 42.84, SD = 15.7) 
participants completed the treatment and were included in the final analysis (See Table 1 for 
demographic and baseline sleep parameters). All participants signed a written informed consent 
form before entering the study, which was approved by the Concordia University Human 
Research Ethics Committee. 
 
Procedure 
 After participants were deemed eligible following the screening PSG, they underwent a 
second sleep recording night within a month before the beginning of the CBT-I sessions, and 
completed a sleep diary for one week and two standardized sleep questionnaires: the Pittsburgh 
Sleep Quality Index (PSQI) [27] and the Insomnia Severity Index (ISI) [28]. Participants then 
completed six, weekly group sessions of CBT-I. Within a month of completion, participants 
completed a third overnight sleep recording, sleep diaries for one week along with the two 














months following CBT-I completion and consisted again of the same two questionnaires (ISI, 
PSQI). 
 
Self-reported sleep measures 
 Sleep quality and insomnia severity were assessed through standardized questionnaires 
and sleep diaries completed both before and after CBT-I. The first questionnaire used was the 
Pittsburgh Sleep Quality Index (PSQI), a self report measure of general sleep quality over the 
past month [27]. The PSQI consists of 7 sub-components (subjective sleep quality, sleep latency, 
sleep duration, habitual sleep efficiency, sleep disturbances, use of medication, and daytime 
dysfunction) calculated through 4 free response questions related to timing of sleep habits and 6 
Likert style questions. Total PSQI score falls on a scale from 0-21 (with higher scores indicating 
worse sleep quality) and has been shown to display an average of 10.38 (SD = 4.57) in 
insomniacs with an overall Cronbach α of 0.83 [27]. The second questionnaire used was the 
Insomnia Severity Index (ISI), a self-report measure of the nature, severity and impact of current 
insomnia symptoms [28]. The ISI consists of 7 Likert style questions with a total score ranging 
from 0-28 (with higher scores indicating more severe insomnia) and an average score reported in 
insomniacs of 19.7 (SD = 4.1) with an overall Cronbach α of 0.74 [28]. Total PSQI and ISI 
scores were used for statistical analyses. While all 24 participants completed these questionnaires 
at baseline and immediately after CBT-I, 17 completed the PSQI and 18 the ISI at 3 months. At 1 
year, 19 participants completed the PSQI and the same 19 also completed the ISI. PSQI and ISI 
scores were the primary outcome variables used to assess CBT-I responses. In addition to these 
questionnaires, sleep diaries based on the consensus sleep diary were given to the participants 














Sleep efficiency (as defined by the ratio total sleep time / time in bed, in %), wake after sleep 
onset (WASO, as defined by the duration of awakenings after sleep onset), sleep latency (i.e., 
latency to sleep onset) and sleep duration (i.e., total sleep time) were extracted from sleep diaries 
by averaging daily values over seven days, including both weekends and weekdays. Sleep 
efficiency, WASO, sleep latency and sleep duration derived from sleep diaries were used as 
secondary variables to assess response to CBT-I. Sleep diaries were completed by 22 out of the 
24 participants at both pre- and post-treatment. 
 
Sleep recordings 
 Sleep recordings (PSG) were obtained at pre- and post-treatment. Participants completed 
three nights of PSG at the PERFORM Centre Sleep Laboratory at Concordia University. The 
first night served as an initial screening (for sleep apnea) and adaptation night, while the second 
served as the baseline experimental night to provide sleep measures before CBT-I (including 
sleep spindles); they were conducted at least 3 days apart. The third PSG was performed within a 
month following the last CBT-I session. For a subset of participants (25%), PSG recordings were 
conducted at home (ambulatory mode) due to ongoing renovations of the sleep laboratory. Since 
these recordings were not conducted in a laboratory environment, there was no adaptation night 
for these 6 participants who thus had two ambulatory PSG recordings (the first at baseline and 
the second after CBT-I). However, all PSG recordings (both in-lab and ambulatory) were 
performed using the same equipment and recording parameters: 34-channel Embla Titanium 
system (Natus Medical, San Carlos, CA, USA) with EEG referenced to linked mastoids 
(bandpass filter 0.3-100 Hz, sampling rate 512 Hz), electrooculography (EOG) and 














recordings included thoracic and abdominal respiration belts, nasal-oral thermocouple airflow, 
and transcutaneous finger pulse oximetry to allow for sleep apnea screening. All participants 
were asked to abstain from caffeine and alcohol on each day of PSG recording. Bedtime and 
awakening times were determined by the participant in accordance with their habitual sleep 
schedule.  
Sleep stages were visually scored according to standard criteria [30] and changes in PSG 
sleep efficiency, WASO, sleep latency and sleep duration from baseline to post-CBT-I were 
calculated as secondary outcome measures of treatment response. Sleep spindles were 
automatically detected during N2 and N3 stages of sleep from the C4-O2 derivation. This was 
chosen due to the prominent detection of spindles over central leads [31]. The spindle detection 
method (Aseega software, Physip, Paris, France) was based on data driven criteria using multiple 
iterations in order to cope with inter-subject and inter-recording variability [32]. It was based on 
an iterative approach. The first iteration aimed at determining recording-specific thresholds, 
based on EEG power ratios in delta, alpha and sigma bands. The second iteration provided 
precise temporal localization of the events. The final iteration enabled the validation of detected 
events based on frequency and duration criteria (> 0.5s). Iteration 1 and 3 dealt with raw EEG 
data, while iteration 2 was applied on the EEG filtered in the spindle (sigma) frequency range 
using frequency bands adapted to each individual based on his/her global spectral profile 
(median values for low and high bands were 11.9 and 15.9 Hz respectively). Spindles were 
quantified according to average density (number per 30 sec. epoch), duration (in seconds), power 
(in squared microvolts), amplitude (maximum, in microvolts), and frequency (in hertz). These 
spindle characteristics were computed for N2-N3 NREM sleep for the whole night. In addition, 














total N2-N3 NREM sleep was calculated using Hanning window and normalized to the global 
spectral power for each 30-sec. epoch: average EEG sigma power was used as an additional 
measure of spindle activity. Likewise, EEG power in the delta frequency range (0.7-4Hz) was 
also calculated, both during total N2-N3 NREM sleep and during the first sleep cycle of N2-N3, 
because EEG delta power during the first NREM sleep cycle was previously shown to be a 
predictor of CBT-I treatment response [13]. Finally, EEG power in other frequency bands 
relevant to sleep, using bands adapted to each individual, were also calculated for total N2-N3 
NREM sleep: theta (median values for frequency range: 4 and 7.9 Hz), alpha (median range: 7.9-
11.9 Hz), and beta (median range: 15.9-50 Hz). These calculations were made to allow 
comparisons with previous reports describing changes in sleep EEG power spectra following 
CBT-I [33].   
 
Cognitive-behavioral therapy for insomnia (CBT-I) 
All participants underwent CBT-I following their baseline assessment. This treatment consisted 
of an empirically-supported 6-week group CBT-I, adapted from [25], comprising 6 modules: 
psychoeducation about sleep and circadian rhythms (week 1); stimulus control (week 1); sleep 
restriction (week 2); sleep hygiene (week 2);  cognitive therapy (week 4); and relaxation (week 
5) [25]. Stimulus control and sleep restriction were also discussed at each session following the 
introduction of these therapeutic strategies. Each group included 4 to 6 participants, for a total of 
5 CBT-I groups in the present study. The treatment was conducted by a licensed clinical 

















 Hierarchical linear modeling (HLM) evaluated changes in insomnia symptoms assessed 
via questionnaires, sleep diaries and PSG from pre- to post-treatment and follow-ups. More 
specifically, HLM assessed the trajectories of changes in total PSQI and ISI scores from pre-
treatment to the 12-months assessment (four time points: pre-treatment, post-treatment, 3 and 12 
months after treatment), and changes in PSQI, ISI, as well as sleep efficiency, WASO, sleep 
latency and sleep duration derived from sleep diaries and PSG from pre- to post-treatment (two 
time points: pre- and post-treatment). The main analysis included time, spindle density and their 
interaction in the model, and evaluated whether pre-treatment spindle density predicted the 
trajectory of changes in PSQI and ISI across the four assessment points. Secondary analyses, also 
including time, spindle density and their interaction in the model, then assessed whether spindle 
density predicted changes in PSQI, ISI, as well as sleep efficiency, WASO, sleep latency and 
sleep duration derived from sleep diaries and PSG from pre- to post-treatment. Our hypothesis 
was focused on spindle density as our main variable of interest, as this measure is commonly 
reported as the primary spindle variable given its stability across nights [23, 34]. Each of the 
other standard spindle measures (spindle amplitude, power, duration, frequency, sigma power) 
[35] and delta power was used as an exploratory variable, replacing spindle density in the model 
for exploratory analyses evaluating if these measures predicted treatment response. Additional 
analyses tested whether sleep spindle density, other spindle measures, as well as EEG spectral 
power in other major frequency ranges relevant to sleep (delta, theta, alpha, beta), changed from 
pre- to post-treatment. All analyses were conducted while adjusting for age, sex, and years of 
education. HLM was used given the nested nature of the data with individual subjects being 














PSQI and ISI for all participants despite some missing data [36]. To illustrate the relationships 
between spindle density and treatment responses, correlations between spindle density at pre-
treatment and sleep changes following CBT-I were also calculated using Pearson's product-
moment correlation. All results were considered significant at p ≤ .05 level. Analyses were 
conducted with SPSS (IBM, New York, NY, USA) and SAS (SAS, Cary, NC, USA) softwares. 
 
RESULTS 
Changes in sleep quality after treatment 
 HLM analyses showed significant decreases for both PSQI (beta = -1.92, SE = 0.32, t = -
5.98, p < 0.001) and ISI (beta = -3.18, SE = 0.39, t = -8.23, p < 0.001) from pre-treatment to 12 
months post-treatment, indicating significant insomnia reduction over time. ISI was reduced on 
average by 8 points from pre- to post-treatment (table 1) and by 10 points from pre-treatment to 
12 months follow-up, which corresponds to an effect size comparable to previous effects 
reported in randomized controlled trials [37]. At post-treatment, 50% of participants were 
considered on remission (as defined by an ISI score below 8) [37] and this percentage was 
further increased to 68% at 12 months. On the sleep diary measure, there was a significant 
increase in sleep efficiency from pre- to post-treatment (beta = 12.59, SE = 3.2, t = 3.93, p < 
0.001). On objective PSG measures, there was a significant increase in sleep efficiency from pre- 
to post-treatment (beta = 6.05, SE = 2.67, t = 2.27, p = 0.03). For means and complete list of 







Age 42.84 (15.7) - - 














PSQI 10.91 (3.52) 5.83 (2.55) -5.08** 
ISI 15.91 (3.13) 8.17 (4.51) -7.74** 
SLD sleep efficiency (%) 72.21 (12.45) 84.8 (10.61) 12.59** 
SLD WASO (min) 55.59 (40.08) 25 (22.93) -30.59** 
SLD sleep latency (min) 48.42 (40.95) 19.59 (15.27) -28.83** 
SLD sleep duration (min) 348.2 (81.69) 382.52 (60.18) 34.32 
PSG sleep efficiency (%) 82.43 (10.69) 87.34 (8.09) 4.91* 
PSG WASO (min) 67.49 (60.44) 41.4 (31.49) -26.09* 
PSG sleep latency (min) 20.82 (17.57) 12.6 (9.19) -8.22* 
PSG sleep duration (min) 385.76 (44.95) 380.68 (72.95) -5.08 
PSG N1 % of TST 9.77 (9.59) 7.22 (5.33) -2.55 
PSG N2 % of TST 61.38 (9.08) 62.18 (8.8) 0.8 
PSG N3 % of TST 9.8 (7.12) 10.61 (6.96) 0.81 
PSG REM % of TST 19.07 (3.65) 19.42 (5.97) 0.35 
Spindle density (nb/30sec N2-N3) 1.27 (0.67) 1.2 (0.68) -0.07 
Spindle duration (sec) 0.88 (0.11) 0.88 (0.1) -0.005 
Spindle amplitude (microV) 10.05 (3.54) 9.96 (3.94) -0.1 
Spindle power (microV2) 30.03 (23.28) 30.23 (25.25) 0.2 
Spindle frequency (Hz) 13.86 (0.37) 13.87 (0.35) 0.004 
Sigma power (normalized) 0.06 (0.02) 0.06 (0.02) 0.0001 
 
Table 1: Demographic characteristics and sleep measures of participants at baseline (pre-
treatment) and immediately after CBT-I (post-treatment) (N = 24, 19 females; N = 22 for sleep 
diary measures). PSQI, Pittsburgh Sleep Quality Index; ISI, Insomnia Severity Index; WASO, 
wake after sleep onset; SLD, sleep diary; PSG, polysomnography; TST, total sleep time 
* p≤0.05; ** p≤0.01 
 
 
Sleep spindle density as predictor of treatment response 
Bivariate Pearson correlations between spindle density at pre-treatment and changes in 














sleep efficiency (r = 0.47, p = 0.03) (Fig. 1) and WASO (r = -0.46, p = 0.03), but not for ISI (r = 
-0.16, p = 0.44). Main analyses using HLM revealed that PSQI changes across the 12-month 
follow-up period were significantly predicted by spindle density, even after adjusting for age, sex 
and years of education (Table 2). Exploratory analyses revealed that spindle amplitude, power, 
duration, as well as sigma power (but not spindle frequency) at baseline also predicted PSQI 
changes over time (Table 2). Lower spindle activity at baseline was associated with smaller 
decreases in PSQI over time, reflecting poorer responses to CBT-I across the follow-up. These 
relationships were also significant when evaluating the effects of spindle activity (density, 
amplitude, power, duration and sigma power) on PSQI changes from pre- to immediate post-
treatment (e.g., for spindle density, beta = -4.66, SE = 1.11, t = -4.18, p < 0.001). ISI changes 
across the follow-up period were not significantly predicted by spindle density or any other 
spindle measures at baseline. However, when restricting the analysis to ISI changes from pre- to 
post-treatment, there was a marginally significant effect of spindle amplitude (beta = -0.42, SE = 
0.24, t = -1.78, p = 0.09) and spindle power (beta = -0.07, SE = 0.04, t = -1.83, p = 0.08), 
reflecting a trend for an association between lower spindle activity and poorer CBT-I response as 
indexed by lower decreases in ISI.  
HLM analyses also indicated that pre-treatment spindle density, as well as spindle 
amplitude, power, duration, and sigma power predicted changes in sleep diary sleep efficiency 
and WASO, but not in sleep latency or duration, as secondary outcome variables from pre- to 
post-treatment (Table 2). Lower spindle activity at pre-treatment was associated with smaller 
increases in sleep efficiency and smaller decreases in WASO from sleep diaries, reflecting 














sleep duration from pre- to post-treatment were not significantly predicted by any of the spindle 
measures.  
 
Parameters ∆ PSQI ∆ ISI 
 beta SE t value p value beta SE t value p value 
Spindle density -1.41 0.63 -2.24 0.03* -0.60 0.75 -0.80 0.42 
Spindle duration -10.14 4.22 -2.40 0.02* -3.98 5.04 -0.79 0.43 
Spindle amplitude -0.20 0.10 -2.00 0.05* -0.07 0.12 -0.61 0.55 
Spindle power -0.03 0.01 -2.00 0.05* -0.02 0.02 -1.09 0.28 
Spindle frequency 0.14 1.05 0.14 0.89 -0.21 1.27 -0.16 0.87 
Sigma power -55.98 20.77 -2.70 0.01** -27.22 26.24 -1.04 0.30 
  
 
 ∆ SLD Sleep Efficiency ∆ SLD WASO 
 beta SE t value p value beta SE t value p value 
Spindle density 16.26 4.79 3.39 0.00** -47.69 14.22 -3.35 0.00** 
Spindle duration 90.48 36.77 2.46 0.02* -278.03 107.01 -2.6 0.02* 
Spindle amplitude 2.30 0.92 2.49 0.02* -8.24 2.67 -3.08 0.00** 
Spindle power 0.31 0.13 2.35 0.03* -1.16 0.4 -2.92 0.00** 
Spindle frequency -10.99 10.41 -1.06 0.31 5.07 31.72 0.16 0.87 
Sigma power 603.43 157.09 3.84 0.00** -1581.39 505.14 -3.13 0.00** 
  
    
 ∆ SLD Sleep Latency ∆ SLD Sleep Duration 
 beta SE t value p value beta SE t value p value 
Spindle density -11.29 17.3 -0.65 0.52 44.17 35.68 1.24 0.23 
Spindle duration -38.36 120.54 -0.32 0.75 116.53 255.53 0.46 0.65 
Spindle amplitude -1.21 3.18 -0.38 0.71 7.69 6.53 1.18 0.25 
Spindle power -0.09 0.46 -0.19 0.85 1.04 0.95 1.09 0.29 















Table 2: Interactions between spindle density during stages N2-N3 of NREM sleep at pre-
treatment and treatment responses as reflected by change in PSQI and ISI from baseline to the 
12- month post-treatment assessment (primary outcomes) and change in sleep diary sleep 
efficiency, WASO, sleep latency and sleep duration from pre-treatment to immediate post-
treatment (secondary outcomes). Exploratory analyses on interactions between other pre-
treatment spindle parameters (duration, amplitude, power, frequency, sigma) and treatment 
responses are also shown.* p≤0.05, ** p≤0.01. These analyses are adjusted for differences in 




Exploratory analyses showed that EEG delta power at pre-treatment during total NREM 
sleep was not predictive of changes in PSQI (beta = -0.18, SE = 7.51, t = -0.02, p = 0.98) or ISI 
(beta = 4.82, SE = 8.98, t = 0.54, p = 0.59) across the follow-up period. Likewise, EEG delta 
power during the first NREM sleep cycle was not predictive of changes in PSQI (beta = -4.68, 
SE = 4.06, t = -1.15, p = 0.25) or ISI (beta = 5.52, SE = 11.20, t = .49, p = 0.63) across the 
follow-up period. Finally neither total EEG delta power nor delta power during the first sleep 














cycle were predictive of changes in PSQI, ISI, as well PSG and sleep diary variables (sleep 
efficiency, WASO, sleep latency and sleep duration) from pre- to post-treatment.  
 
Changes in spindle activity following treatment 
HLM revealed no significant change in any of the spindle parameters from pre- to post-
treatment: spindle density (beta = -0.08, SE = 0.09, t = -0.89, p = 0.38), duration (beta = -0.005, 
SE = 0.009, t = -0.48, p = 0.63), amplitude (beta = 0.04, SE = 0.73, t = 0.05, p = 0.96), power 
(beta = 0.48, SE = 3.89, t = 0.12, p = 0.9) and frequency (beta = 0.005, SE = 0.05, t = 0.10, p = 
0.92). Further, no significant treatment-related changes were observed for EEG sigma power 
(beta = -0.00008, SE = 0.003, t = -0.02, p = 0.98), delta power (beta = -0.002, SE = 0.009, t = -
0.18, p = 0.86), theta power (beta = 0.006, SE = 0.006, t = 0.97, p = 0.34), alpha power (beta = -




 These preliminary results provide support to our hypothesis that spindle density at pre-
treatment predicts individual’s response to CBT-I, both in the short- (immediate post-treatment) 
and long-term (12-month follow-up). In this pilot study, CBT-I was associated with sustained 
improvements in insomnia symptoms with effect sizes comparable to published randomized 
controlled trials [37]. Sleep spindle density at pre-treatment was predictive of these 
improvements, particularly in PSQI and sleep diary sleep efficiency and WASO, with lower 
spindle density being related to smaller improvements in these sleep quality measures. 














treatment change in ISI score. These results suggest that sleep spindle activity might thus 
identify a specific insomnia phenotype with a physiological vulnerability to sleep disruption that 
is less responsive to CBT-I.  
Previous work suggests that lower spindle density may be a predisposing factor in the 
development of exacerbation of sleep problems in response to stress [22] and this current study 
suggests that weaker spindle density might also hinder response to CBT-I treatment. Current 
knowledge on sleep spindles suggests two non-mutually exclusive interpretations for why 
weaker spindles might hinder CBT-I treatment. Sleep spindles have been associated with the 
gating of external auditory stimuli during sleep [20], and thus contribute to isolate the cortex 
from noise that could disrupt sleep. Accordingly, greater spindle density has been associated 
with the ability to maintain stable sleep in the face of noise [21]. Individuals with weaker spindle 
traits may thus have more difficulty maintaining stable sleep despite their efforts to incorporate 
the CBT-I components due to a persistence of lower arousal threshold to external stimulation 
during sleep. This is in line with our findings that lower spindle activity predicts worse 
improvements in sleep diary variables related sleep stability, i.e. sleep efficiency and WASO, but 
not in sleep duration or latency to sleep onset, which suggests that spindle activity may be more 
predictive of changes in sleep maintenance difficulties rather than sleep initiation problems. In 
addition, since spindle activity is associated with memory consolidation and general intellectual 
abilities [18, 19], insomniacs with weaker spindles may also have more difficulties incorporating 
CBT-I components into their daily lives because of their lower ability to learn new information 
and strategies efficiently. However, education level – as a proxy for overall cognitive abilities - 
was not found to be predictive of CBT-I response for any of our sleep outcomes in the present 














with an overarching theory of insomnia, which posits that insomniacs are in a psycho-
physiological state of hyperarousal [38]. Reduced spindle activity may contribute to a state of 
physiological hyperarousal through a lower arousal threshold to external stimulation during 
sleep, while a state of psychological hyperarousal may be more prominent in insomniacs with 
preserved spindle activity. As CBT-I has been developed to target the psychological components 
of hyperarousal rather than its physiological components [25], it would be expected as less 
effective for individuals in which reduced spindle density would exacerbate physiological 
hyperarousal.  
In line with the concept of spindle density as a trait-like biomarker, spindle measures did 
not change after CBT-I, which suggests that spindle activity is a stable trait not impacted by 
CBT-I. This is important given that psychological factors previously studied as predictors of 
treatment response (e.g., depression, anxiety, dysfunctional beliefs about sleep) showed 
significant changes following CBT-I [5, 7, 9], which suggests that their relationships with CBT-I 
response might represent an epiphenomenon of their propensity to change with CBT-I rather 
than true vulnerability factors that predict treatment response. Besides spindle activity, there was 
no significant change of EEG spectral power in any of the frequency bands relevant to sleep 
(delta, theta, alpha, sigma, beta) following CBT-I. These findings contrast with those previously 
reported on a sample of 9 individuals with chronic insomnia, showing an increase in slow wave 
activity (0.5-4.75Hz) and decreases in the other frequency bands, including sigma, after 8 weeks 
of CBT-I [33]. Several methodological differences might explain this discrepancy. For example, 
we did not use fixed frequency bands (as in [33]) but resorted to adapted frequency bands 
reflecting the individual spectral profile. In addition, our findings were based on a larger sample 














sample characteristics might also have contributed to these differences. For instance, average 
PSG sleep efficiency and total sleep time were lower in that previous study (67.41% and 323.67 
min.) than in our sample (82.43% and 348.2 min.), which might suggest that changes in EEG 
spectral power following CBT-I are predominantly found in chronic insomniacs with more 
objective sleep disturbances. 
 In contrast to a previous study by Krystal and Edinger, no association was found between 
delta power at baseline and treatment outcomes [13]. The previous study found an effect only for 
delta in the first cycle. Here, there was no effect of delta power either during the whole night or 
in the first sleep cycle only. This may be due to differences in the age range of participants 
between studies. In the previous study, subjects ranged between 40 and 80 years old with an 
average of 54.9 years, whereas in the present study subjects ranged from around 19 to 72 years 
with an average age of 42.84 years and half of the subjects below the age of 40. This is relevant 
as delta-rich slow wave sleep has been noted to decrease with age, particularly around 30-40 
years [39]. It may be the case that lower first cycle delta power is only predictive in older 
individuals who as a group already have lower baseline delta power than younger individuals. 
Methodological differences in the spectral analyses (e.g., frequency bands) may also have 
contributed to this difference. 
 There are some limitations to our study. Firstly, it was designed as a pilot study to 
provide preliminary findings that would guide future larger confirmatory studies. Indeed, the 
absence of significant effects on ISI was likely due to a lack of statistical power, as suggested by 
the marginal effects observed between spindle amplitude or power and ISI. This lack of power 
might also explain the absence of significant effects on PSG-derived sleep outcomes (e.g., PSG 














variables following CBT-I was more limited compared to the corresponding sleep diary variables 
(e.g., mean sleep efficiency increase was of 4.9% for PSG and 12.6% for sleep diaries). In 
addition, the recording of multiple PSG nights at each assessment time and/or the use of other 
objective assessments such as actigraphy over several days might also be useful in future 
replication studies to assess relationships with objective sleep outcomes, given the night-to-night 
variability in insomnia symptoms. Secondly, in the absence of a control group or a control 
intervention, we cannot evaluate whether these predictive relationships were specific to CBT-I. 
Future studies should investigate if spindle activity also predicts sleep changes following other 
interventions or the natural course of insomnia over time. Thirdly, a minority (6) of our 
participants underwent home-based ambulatory PSG while the majority (18) had their PSG 
performed in the laboratory. To minimize the impact of this difference in recording environment, 
we used similar PSG systems and recording parameters for both ambulatory and lab-based PSG. 
In addition, we also ran additional analyses excluding the 6 participants recorded from home, and 
found that the effects of spindle density on sleep changes following CBT-I remained significant 
(e.g., effects of spindle density on PSQI changes: beta = -4.1, SE = 1.34, t = -3.05, p = 0.009). 
This suggests that the presence of ambulatory recordings did not confound our results. 
If our results are replicated, the present findings may have clinical implications. In a 
personalized medicine approach, spindle activity as a neurophysiological predictor of treatment 
response could serve as a prognostic tool to guide the selection of the most appropriate treatment 
regimen. The identification of reliable predictors of treatment response is critical in a context of 
limited CBT-I accessibility, in order to prioritize CBT-I resources to those patients who are the 
most likely to respond. Spindle activity is an objective trait biomarker that can be measured in 














channels, and could thus be implemented as a prognostic biomarker in clinical practice for the 
design of the individualized therapeutic approach. Furthermore, these findings may point to other 
forms of treatment modifying brain oscillations that may be effective for the insomnia phenotype 
characterized by low spindle activity. By targeting sleep spindles, these alternative treatments 
would aim at reversing the specific neural abnormalities characterizing subgroups of insomniacs. 
Previous studies have shown that it is possible to alter spindle parameters with pharmacological 
treatments (e.g., benzodiazepine and non-benzodiazepine hypnotic drugs) [40], as well as non-
pharmacological interventions such as transcranial direct electrical stimulation [41] and 
neurofeedback [42]. Further investigation is needed to assess whether these treatments could be 
of interest for insomniacs for whom lower responsiveness to CBT-I would be expected. Larger 
clinical trials will be needed to test these potential clinical implications.  
 In summary, our results provide preliminary evidence that sleep spindle density at pre-
treatment might predict who will show better response to CBT-I. Spindle density within the 
population of chronic insomniacs may be an endogenous biomarker that contributes to identify 
different phenotypes of insomnia with different treatment responsiveness. This new finding may 
guide future algorithms for insomnia treatment, which could be tailored based on these 
individual differences. Future studies are needed to confirm and extend these findings in larger 
samples, including insomniacs with comorbid medical or psychiatric conditions. Further research 
should also seek to evaluate which therapeutic interventions would be most effective in 
insomniacs with lower spindle activity, including the investigation of pharmacological and non-
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• Spindles may predict responsiveness to cognitive-behavioral therapy for insomnia 
(CBT-I).  
• Lower spindle density was prospectively associated with smaller responses to 
CBT-I.  
• Spindles might thus constitute a biomarker identifying patients less responsive to 
CBT-I.  
